|
||
|
Affinium Pharmaceuticals
Download PDF Members: Affinium Pharmaceuticals is a specialty pharmaceutical company focused on the discovery, development and commercialization of novel anti-infective medicines. AFN-1252 utilizes a unique mechanism of action by directly inhibiting the function of the bacterial fatty acid synthesis (FAS) II pathway. Affinium’s FASII antibacterial programs constitute a new antibiotic franchise with the potential for multiple products targeting the FASII pathway. These programs include a broad base of long-term intellectual property: issued and pending composition of matter patents on potent orally available small molecule inhibitors of a new class of antibiotics with a unique mechanism of action, targeting an underexploited pathway and are not subject to resistance selection pressures caused by the use of existing broad spectrum antibiotics.
This page has been viewed 989 times since April 2007, the link to the organisation's website has been followed 129 times Recent Search Terms used to find this page: pharmaceuticals in toronto | Fate Therapeutics contacts | affinium private equity | f | affinium pharmaceuticals canada | Affinium COMPLETE PROFILE | @afnm.com | affinium pharmaceuticals in ontario canada | Affinium Pharmaceuticals Fab | affinium pharmaceutical toronto | . Search for more companies in Toronto Search for more companies in Ontario This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Affinium Pharmaceuticals | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nothing in this website should be used in place of personal medical
advice from your own qualified medical practitioner. See
User
Agreement |
All rights reserved. All other trademarks recognized. |
|
|